Injectable Decorin/Gellan Gum Hydrogel Encapsulating Adipose-Derived Stem Cells Enhances Anti-Inflammatory Effect in Cartilage Injury via Autophagy Signaling

Abstract

Adipose-derived stem cells (ADSCs) are employed as a promising alternative in treating cartilage injury. Regulating the inflammatory “fingerprint” of ADSCs to improve their anti-inflammatory properties could enhance therapy efficiency. Herein, a novel injectable decorin/gellan gum hydrogel combined with ADSCs encapsulation for arthritis cartilage treatment is proposed. Decorin/gellan gum hydrogel was prepared according to the previous manufacturing protocol. The liquid–solid form transition of gellan gum hydrogel is perfectly suitable for intra-articular injection. Decorin-enriched matrix showing an immunomodulatory ability to enhance ADSCs anti-inflammatory phenotype under inflammation microenvironment by regulating autophagy signaling. This decorin/gellan gum/ADSCs hydrogel efficiently reverses interleukin-1β-induced cellular injury in chondrocytes. Through a mono-iodoacetate-induced arthritis mice model, the synergistic therapeutic effect of this ADSCs-loaded hydrogel, including inflammation attenuation and cartilage protection, is demonstrated. These results make the decorin/gellan gum hydrogel laden with ADSCs an ideal candidate for treating inflammatory joint disorders.

Keywords

ADSCs decorin gellan gum autophagy arthritis

Introduction

Intra-articular injection of adipose-derived stem cells (ADSCs) has been developed as an important therapeutic approach to address arthritis symptoms distributed from animal models¹ to clinical practice². ADSCs can be harvested easily and repeatedly with minimally invasive liposuctions in clinical practice. Clinical outcomes including functional improvement and pain relief have been revealed by therapeutic applications on osteoarthritis (OA)^3
–5, rheumatoid arthritis (RA), and cartilage defect disorder^6,7. The existing inflammatory microenvironment is the main cause of cartilage degradation and pain since the inflammatory cytokines induce an increase in metalloproteases expression enhancing cartilage degradation^8,9. ADSCs regulate inflammatory milieu in the chronic inflammatory joint disorder by modulating pro-inflammatory cytokines interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-alpha (TNF-α) and governing immunomodulated anti-inflammatory effects^10
–12. On the contrary, the articular inflammatory microenvironment also has a huge impact on the inflammatory phenotype of ADSC. A previous study suggested that inflammatory commitment of ADSC induced by IL-1β activates nuclear factor kappa-B signaling in chondrocytes and synoviocytes¹³. Furthermore, TNF-α exposure inhibited glycosaminoglycan (GAG) deposition and chondrogenic gene expression in ADSCs¹⁴, indicating that the pro-inflammatory microenvironment could hamper the therapeutic efficiency of ADSC by cytokines interaction. Therefore, regulating the inflammatory “fingerprint” of ADSC and maintaining its anti-inflammatory potential is crucial to the success of ADSC-injected therapy.

Mesenchymal stem cells (MSCs) chondrogenesis involved harmonious crosstalk between extracellular matrix (ECM) components and MSCs¹⁵. Decorin, a small leucine-rich proteoglycan within cartilage ECM¹⁶, enhanced chondrogenic differentiation of MSCs in gel matrix by inducing GAG and type II collagen deposition¹⁷. Interaction between sulfate chains on decorin and peripheral cells controlled the biomechanical environment and the biochemical transduction into cartilage cells^18,19. Indeed, loss of decorin resulted in greater GAG loss and formation of severer OA symptoms in the post-traumatic OA model²⁰, indicating a protective role of decorin in late-stage cartilage degeneration²¹. Interestingly, patients with spondyloarthropathies showed upregulated decorin antibody levels in synovial fluid compared with OA patients²², suggesting an involved role of decorin in regulating inflammatory rheumatic diseases. Of note, alleviation of antigen-induced arthritis by corticosteroid administration elevated decorin mRNA levels in connective tissues²³. Furthermore, co-culture MSCs could reduce the pro-inflammatory effect of TNFα and IL-1β on cartilage by increasing decorin secretion²⁴, in line with the fact that decorin may interact with extracellular tyrosine kinase receptors for immunol signaling transduction in inflammatory diseases²⁵. Given the fact that decorin-overexpressed MSCs significantly attenuate inflammation by regulating immune responses²⁶, we therefore wonder whether pericellular decorin would enhance the anti-inflammatory property of ADSCs that facilitate cartilage repair.

Recent studies from the L.M. Grover research group developed decorin-encapsulated gellan gum hydrogel for sustained release of decorin and delivering anti-inflammatory effect^27,28. The transition of solid to fluid-forming hydrogel under shear stress makes it as ideal for injection into the intra-articular space. Integrated MSCs with gellan gum hydrogel have been shown effective for osteochondral repair²⁹. In addition, decorin shows regulating immune cell dynamics³⁰ via mediating outside-in innate autophagy signaling³¹. Inhibiting autophagy is associated with cartilage matrix degeneration³². In particular, autophagy is required to maintain the anti-inflammatory potential of ADSCs^33,34, whereas inhibition of autophagy mediated stress-induced apoptosis in ADSCs³⁵. Despite the previous study indicating that decorin induces autophagy signaling in different cell types^36,37, its precise role play in ADSC phenotype during inflammation is unclear.

In this study, we intend to evaluate the introduction of ADSCs within decorin-loaded gellan gum hydrogel on articular therapy in inflammatory joint disorder. This formulation not only aimed at improving the ADSCs regenerative function at the articular cartilage but also took advantage of the immunomodulatory properties of decorin. The immuno-modulation role of decorin functions not only at ADSCs in the inflammatory microenvironment but also in the chondrocytes via a sustained release. Our results here may represent an easy and effective route to improve the anti-inflammatory capacity of ADSCs for intra-articular injection therapy.

Materials and Methods

Isolation of Mouse ADSCs

Isolation of ADSCs was performed according to previous reports^38,39. Briefly, the inguinal subcutaneous fat was collected from C57BL/6 mice (male, 10 weeks old). The adipose was minced into pieces less than 1 mm in diameter. Digestion was performed with 0.1% type I collagenase (Gibco, United States) at 37°C for 45 min. After neutralization, the collected cells were seeded to a final concentration of 5 × 10⁶ cells/ml. The cells were cultured in a 37°C incubator supplied with 5% CO₂ and 95% humidity. The third- or fourth-passage cells were used for the following experiments. Characterization of the ADSCs through flow cytometry and differentiation assay has been performed according to our previous study³⁹.

Decorin/Gellan Gum Hydrogel Preparation and ADSCs Encapsulation

Decorin/gellan gum hydrogel was performed according to previous report²⁷ with slight modification. Briefly, gellan powder was dissolved in deionized water for 1% (w/v) solution with heating to 70°C. After dissolving, gellan sol was added to the rotational rheometer (Fig. 1A, Brookfield, United States) and cooled to 50°C. Decorin from bovine articular cartilage (Sigma, Germany) and sodium chloride (0.2 M) were added to gellan sol for final concentrations of 0.9% (w/v) gellan, 0.24 mg/ml Decorin, and 10 mM sodium chloride (NaCl). Finally, the whole mixture was cooled at a rate of 1°C/min to a final temperature of 24°C under shear (450/s). In the case of a hydrogel loaded with ADSCs, suspension of ADSCs at a final density of 1 × 10⁶ cells/ml was mixed into the mixture under shear (100/s) in 1 min followed by further experiments.

Figure 1.

Decorin-laden gellan gum hydrogel production and physiochemical property analysis of the decorin/gellan gum/ADSCs hydrogel. (A) Representative figure of the rotational rheometer used in this study. Viscosity characterization of the decorin/gellan hydrogel by applying shear (n = 2). (B) Optical images of the post-shearing hydrogel with syringe injection. (C) Cumulative release curve of the decorin-enriched hydrogel over 180 min. (D) Scanning electron microscopy (SEM) characterization image of the decorin/gellan/ADSCs hydrogel illustrating the forming gel structure. Scare bars: 100 μm. (E) Representative image of 4′,6-diamidino-2-phenylindole (DAPI) staining identifies ADSCs encapsulation in hydrogel on day 1. (F) Swelling degree test of three groups of hydrogels (n = 3). ADSCs: adipose-derived stem cells.

Scanning Electron Microscopy Analysis

Solid form ADSCs/decorin/gellan gum hydrogel was immersed in 2.5% glutaraldehyde for fixation for about 1 h. Dehydration was performed with graded ethanol (50%, 70%, 80%, 90%, 95%, and 100%) and lyophilized for 12 h to eliminate residual water. All samples were sputter-coated with platinum and imaged with an ULTRA 55 scanning electron microscope (SEM; Carl ZEISS AG, Germany).

In Vitro Decorin Release

Cumulatively release levels of decorin from the hydrogel were determined according to a previous study²⁷. A total of 1 ml of the solid decorin/gellan gum hydrogel was soaked in 2 ml of Dulbecco’s Modified Eagle Medium (DMEM) and incubated at 37°C. At a certain time point, the medium was removed for measurement by enzyme-linked immunosorbent assay (ELISA). Decorin cumulatively released was quantified using Bovine Decorin ELISA (Sigma, RAB1185, Germany) following the manufacturer’s protocol.

Swelling Assay

The swelling behavior of hydrogels was performed as described before⁴⁰. Briefly, 200 mg (M0) of lyophilized hydrogel was soaked in 20 ml of normal saline solution. At every time point, the hydrogels were removed and immediately weighed (M1). The swelling behavior was calculated as Swelling (%) $= ((M 1 - M 0) / M 0) \times 100$ .

Live/Dead Assay

A Live/Dead cell imaging kit (Invitrogen, R37601) was used to determine the effect of IL-β (20 ng/mL) with/without decorin on ADSC viability according to the manufacturer’s protocol. Images were taken with a fluorescence microscope (Leica, Germany) at ex 488 nm and ex 570 nm.

Cell Proliferation Assay Under Inflammation

The ADSCs were seeded onto the hydrogels at the density of 1 × 10⁶ cells/ml. Then IL-1β (20 ng/ml) was added to each well and incubated for 24 h. Cell proliferation assay was evaluated using Cell Counting Kit-8 (CCK-8, Sigma-Aldrich) according to the manufacturer’s instructions.

Co-culture System

The Transwell co-culture system was performed as described before⁴¹. A number of 5 × 10⁴ primary chondrocytes were seeded into a 24-well plate. Cells were incubated with/without 20 ng/ml IL-1β for 12 h. After induction of inflammation, ADSCs/decorin/gellan gum hydrogel was added into transwell inserts for co-culture with inflamed chondrocytes for another 12 h. ADSCs or chondrocytes were collected and used in the following Quantitative Real-time Polymerase Chain Reaction (qRT-PCR) analysis.

Quantitative Real-time Polymerase Chain Reaction

Total RNA from ADSCs or chondrocytes was extracted using TRIzol (Invitrogen, Germany). The qRT-PCR assay was performed using the ABsolute Real Time PCR SYBR Master Mix (Invitrogen, AB1162B) on a 7000 PCR System according to the manufacturer’s instructions. The fold change in the expression of the sample was calculated using the ΔΔCt comparative method. Primers used in this study are listed in Table 1.

Table 1.

Mus Musculus Primers Used in This Study.

GENE	Forward	Reverse
SOX9	AGTACCCGCATCTGCACAAC	ACGAAGGGTCTCTTCTCGCT
Col2a1	GGGAATGTCCTCTGCGATGAC	GAAGGGGATCTCGGGGTTG
Aggrecan	CCTGCTACTTCATCGACCCC	AGATGCTGTTGACTCGAACCT
Runx2	GACTGTGGTTACCGTCATGGC	ACTTGGTTTTTCATAACAGCGGA
MMP-13	CTTCTTCTTGTTGAGCTGGACTC	CTGTGGAGGTCACTGTAGACT
ADAMTS5	GGAGCGAGGCCATTTACAAC	CGTAGACAAGGTAGCCCACTTT
TNF-α	GGTGCCTATGTCTCAGCCTCTT	GCCATAGAACTGATGAGAGGGAG
IL-6	TAGTCCTTCCTACCCCAATTTCC	TTGGTCCTTAGCCACTCCTTC
GAPDH	AGGTCGGTGTGAACGGATTTG	TGTAGACCATGTAGTTGAGGTCA
β-Actin	ACTCTTCCAGCCTTCCTTC	ATCTCCTTCTGCATCCTGTC

ADAMTS5: ADAM metallopeptidase with thrombospondin type I Motif 5; Col2a1: collagen type II alpha 1 chain; IL-6: interleukin-6; MMP-13: matrix metalloproteinase 13; Runx2: Runt-related transcription factor 2; SOX9: SRY-box transcription factor 9; TNF-α: tumor necrosis factor-alpha; GAPDH: Glycerinaldehyd-3-phosphat-Dehydrogenase.

Western Blotting

ADSCs were harvested and homogenized in Radioimmunoprecipitation assay (RIPA) lysis buffer. Protein concentration was determined using a bicinchoninic acid (BCA) assay (Invitrogen, Germany). After gel running, samples were blocked with 5% skim milk and incubated with primary antibodies at 4°C overnight: LC3A/B (CST, 1:1,000, 4108), p62 (CST, 1:1,000, 23214), and β-actin (CST, 1:1,000, 3700). Samples were rinsed three times with PBST and incubated with indicated secondary antibodies for 2 h at room temperature. Samples were developed with Immobilon Western Chemilum HRP Substrate (Millipore, WBKLS0500) for 1–2 min. The band density for each sample was determined relative to β-actin.

Animal Experiments

The mono-iodoacetate (MIA)-induced OA animal study was conducted under the guideline of the National Institutes of Health Guide for the Care and Use of Laboratory Animals and ARRIVE guidelines. A total of 38 adult male C57BL/6 mice (10 weeks old) were randomly divided into the following groups: (1) SHAM = 3; (2) SHAM + gellan/deocrin/ADSCs hydrogel = 3; (3) MIA = 6; (4) MIA + gellan gum hydrogel = 6; (5) MIA + gellan/decorin hydrogel = 6; (6) MIA + gellan/ADSCs hydrogel = 6; and (7) MIA + gellan/decorin/ADSCs hydrogel = 8. PBS intra-articular injection serves as the SHAM group. The MIA OA model was generated according to the previous report with slight modification⁴². Briefly, under anesthesia, an intra-articular injection of 0.25 mg of MIA was performed into the left knee. In the treatment groups, OA induction was followed by their respective treatments: Intra-articular injection of hydrogel for once on 7 days post-MIA injection. Tissue was collected at 14 days post-MIA injection.

Masson’s Trichrome Stain Assessment, Imaging, and OARSI Scoring

The collected specimens of the knee joint were fixed in 4% paraformaldehyde, decalcified in 10% EDTA decalcification solution for 2 weeks, and embedded in paraffin. The specimens were sectioned at 5 μm thickness in the sagittal plane and prepared for Masson’s trichrome stain analysis. Sections were hydrated to distilled water and mordant in Bouins’s solution for 5 min. After washing three times, they were kept in modified Weigert’s iron hematoxylin for 5 min. Then Biebrich Scarlet-Acid Fuchsin solution was used for 5 min, followed by 1% phosphomolybdic acid solution for 3 min and Aniline Blue solution for 10 min. Sections were imaged on a Zeiss Axioscanner fluorescent microscope. The Osteoarthritis Research Society International (OARSI) scoring was performed as a recommended scoring system for mice⁴³.

Cytokines Evaluations

The synovial membranes were collected and lysed. The ELISA kits (MTA00B, MLB00C, D6050, R&D, United States) were employed to test the cytokines (TNF-α, IL-1β, and IL-6) in synovium samples according to the manufacturer’s instructions.

Statistical Analysis

All statistical analysis was performed using GraphPad Prism version 7.0 (GraphPad Software, La Jolla, CA, United States). Statistical significance was determined at p < 0.05. Statistical differences between the two groups were using Student’s t-test. Statistical differences among groups were analyzed using one-way variance with Tukey’s post hoc tests. For the data that were not normally distributed, a non-parametric Mann–Whitney t-test was used.

Results

Decorin-Laden Gellan Gum Hydrogel Formulation and ADSCs Encapsulation Properties

First, we studied the viscosity–shear rate profiles of decorin-laden hydrogel. As shown in Fig. 1A, time-dependent viscosity profiles highlight the degree of thixotropy of decorin-laden hydrogel. The viscosities of hydrogel were around 10,000 mPa·s at a shear rate of 1/s. Increasing the shear force exerted on the hydrogel results in shear-thinning behavior, indicating that the post-sheared hydrogel exhibited typical liquid-like property which is suitable for applying syringe (27G) injection (Fig. 1B). After hydrogel formulation, we evaluated the rate of decorin release by determining the cumulative release curve (Fig. 1C). Release of decorin from the hydrogel was calculated approximately linear over time (y = 0.0752+0.103x−0.0001x², R² = 0.9851). After shearing and cooling, “rope-like” gelled entities were synthesized and were analyzed by SEM image (Fig. 1D). As shown in Fig. 1E, DAPI staining in hydrogel on day 1 could observe encapsulated ADSCs in decorin/gellan gum hydrogel. We further found that the swelling ratio of the hydrogel declined with the encapsulation of ADSCs (Fig. 1F). Proper hydrogel formulation could ameliorate the survival of ADSCs and preserve functional property. Taken together, these results indicated that ADSCs could be successfully and effectively encapsulated into decorin/gellan gum hydrogel.

Biocompatibility and Chondrogenesis Regulation of ADSCs by Decorin-Laden Hydrogel Under Inflammatory Stress

ADSCs encapsulated in different hydrogels can still proliferate and differentiate into cartilage cells. To evaluate the biocompatibility of ADSCs in the deocrin/gellan gum hydrogel under inflammatory stress, IL-1β (20 ng/mL) was treated with or without decorin loading. Live/dead cell staining analysis indicated ADSCs encapsulated in decorin-laden hydrogel after culture for 7 days displayed a high rate of cell viability under IL-1β stimulation when compared with ADSCs encapsulated in gellan hydrogel (Fig. 2A, B). Of note, the cell viabilities of ADSCs encapsulated in decorin/gellan gum hydrogel showed significant differences with increased IL-1β concentration (from 10 to 40 ng/ml) while compared with non-decorin loading (Fig. 2C), suggesting a protection role of decorin against inflammation-induced cell death on ADSCs.

Figure 2.

ADSCs in vitro biocompatibility evaluation in the decorin/gellan gum hydrogel with IL-1β. (A, B) Representative images of live/dead images of ADSCs cultured in the decorin/gellan gum hydrogel on days 1 and 7 with IL-1β (20 ng/mL) stimulation (n = 3). Scare bars: 200 μm. (C) CCK-8 assay identified ADSCs viabilities encapsulated in the decorin/gellan gum hydrogel with increased IL-1β concentration (from 10 to 40 ng/ml, n = 3). ADSCs = adipose-derived stem cells; CCK-8 = Cell Counting Kit-8; IL-1β = interleukin-1β.

We then compared the ability of decorin-laden hydrogels to regulate the chondrogenic differentiation of ADSCs under inflammatory stress by measuring the expression of chondrogenic-related genes, including SRY-box transcription factor 9 (SOX9), collagen type II alpha 1 chain (Col2a1), aggrecan (ACAN), and Runt-related transcription factor 2 (Runx2). After in vitro chondrogenic differentiation for 14 days, the mRNA expression levels of SOX9, Col2a1, and ACAN significantly increased in ADSCs encapsulated decorin hydrogel under IL-1β stimulation, while the expression of the OA-related gene Runx2 showed significant decreased (Fig. 3). These results suggested that the decorin/gellan gum hydrogel could protect the chondrogenic differentiation ability of ADSCs in the inflammation microenvironment.

Figure 3.

The chondrogenic differentiation analysis of ADSCs under inflammatory stress. Quantitative real-time PCR analysis of the expression of SOX9, Col2a1, ACAN, and Runx2 in ADSCs encapsulated in the decorin/gellan gum hydrogel with or without IL-1β stimulation (n = 4). ADSCs = adipose-derived stem cells; IL-1β = interleukin-1β.

Decorin/Gellan Hydrogel Modulate Autophagy Signaling in ADSCs Under Inflammatory Stress

Decorin was known to induce autophagy signaling in different cell types⁴⁴. During autophagy, cytoplasmic LC3 protein (LC3-I) is conjugated to phosphatidylethanolamine for lipidation to form LC3-phosphatidylethanolamine conjugate (LC3-II) and then recruited to the autophagosome membranes^45,46. The ubiquitin-associated protein p62 binds to LC3 and entraps in autophagosome; therefore, decreased expression of p62 is commonly considered upregulated autophagy signaling. IL-1β-induced inflammation interferes with autophagy signaling in ADSCs, as indicated by upregulated LC3-II and p62 protein expression (Fig. 4). Of note, enhanced p62 expression in acute inflammation via impaired proteasomal degradation is associated with IL-1β production⁴⁷. Importantly, decorin-loaded hydrogels restored the autophagy signaling in ADSCs, as suggested by upregulated p62 protein expression (Fig. 4) when compared with IL-1β treatment. A previous study has shown that 200 nM decorin stimulation on endothelial cells for 12 h effectively activates the LC3-I/LC3-II conversion⁴⁸ and increases p62 degradation⁴⁹. However, loading with gellan gum hydrogel only did not show a significant change in p62 protein expression. These above results proved that the decorin/gellan gum hydrogel could attenuate the autophagy destruction in ADSCs with IL-1β-induced inflammation challenges.

Figure 4.

Decorin/gellan gum hydrogel regulates autophagy signaling in ADSCs under IL-1β stress. WB analysis of the expression of autophagy-related genes LC3-I, LC3-II, and p62 in ADSCs encapsulated in the decorin/gellan gum hydrogel with or without IL-1β stimulation (n = 3). ADSCs = adipose-derived stem cells; IL-1β = interleukin-1β.

In Vitro Chondrocytes Protection and In Vivo Cartilage Repair Assays of Decorin/Gellan/ADSCs Hydrogel

To determine the protected effect of decorin/gellan/ADSCs hydrogel on chondrocytes, a co-culture transwell system was used. IL-1β stimulation significantly induced mRNA expression levels of inflammatory genes in chondrocytes, including matrix metalloproteinase 13 (MMP-13), ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS5), TNF-α, and IL-6 (Fig. 5). However, placement of decorin/gellan/ADSCs hydrogel in upper transwell chamber decreased the mRNA expression levels of OA-related genes, indicating that decorin/gellan/ADSCs hydrogel may provide protection on chondrocytes through cytokines paracrine signaling or decorin released.

Figure 5.

In vitro evaluation of chondrocytes protection in a co-culture system. The qRT-PCR of the expression of OA-related genes MMP-13, ADAMTS5, TNF-α, and IL-6 in chondrocytes with or without the decorin/gellan/ADSCs hydrogel treatment under IL-1β stimulation (n = 4). ADSCs = adipose-derived stem cells; IL-1β = interleukin-1β; OA = osteoarthritis; TNF-α = tumor necrosis factor-alpha.

After comparatively analyzing the ability to provide chondrocyte protection in vitro, we tested the ability of the hydrogel to attenuate cartilage injury in vivo. Hydrogels loaded with different components were injected into mice knee joint with MIA-induced cartilage damage (Fig. 6A). Masson’s trichrome staining showed that apparent cartilage damage in the MIA group and MIA + gellan gum group (MIA + G), as reflected by GAG denaturation on the cartilage surface and collagen matrix disorganization (red staining). As expected, injection of gellan/decorin hydrogel (MIA + G/D) slightly suppressed cartilage degeneration in the MIA model, while injection of gellan/ADSCs hydrogel (MIA + G/A) significantly decreased cartilage injury, as shown by improvement of the structural integrity in cartilage. Interestingly, a synergistic therapeutic effect of decorin and ADSCs was displayed by better protection on tibial cartilages injury (Fig. 6A). In line with this result, analysis of the OARSI score showed that the decorin/gellan gum/ADSCs hydrogel injection group displayed significantly lower scores than gellan gum/ADSCs hydrogel injection group (Fig. 6B). Furthermore, MIA-induced inflammatory factor (TNF-α, IL-1β, and IL-6) upregulation in the synovial membrane was significantly attenuated by intra-articular application of decorin/gellan gum/ADSCs hydrogel (Fig. 6C). Taken together, the above results indicated that the decorin/gellan gum/ADSCs hydrogel presented better in vivo cartilage protection ability in inflammatory arthritis when compared with intra-articular injection of decorin/gellan gum/ hydrogel or ADSCs/gellan gum/ hydrogel.

Figure 6.

In vivo evaluation of cartilage protection by the decorin/gellan gum/ADSCs hydrogel in the MIA models. (A) Representative Masson’s trichrome staining images of mouse cartilage injuries in different hydrogel groups. (B) OARSI histological assessment score in different hydrogel groups. (C) The ELISA assay was employed to test the cytokines TNF-α, IL-1β, and IL-6 in synovium membranes from different hydrogel groups (G, gellan gum; D, decorin; A, ADSCs). ADSCs = adipose-derived stem cells; ELISA = enzyme-linked immunosorbent assay; IL-1β = interleukin-1β; MIA = mono-iodoacetate; TNF-α = tumor necrosis factor-alpha.

Discussion

This study aimed to determine the regulated effect of decorin-rich gellan gum hydrogel on ADSC regenerative phenotype under the inflammatory microenvironment. Our results demonstrate that encapsulation ADSCs within a decorin-enriched gellan gum not only regulated their proliferation activity under inflammation but also supported their chondrogenesis in favor of cartilage regeneration. The underlying mechanism may be related to the regulation of ADSCs autophagy signaling in the inflammatory microenvironment. Of note, a synergistic effect of ADSCs on articular therapy in inflammatory joint disorder was achieved by combining with decorin-loaded gellan hydrogel, suggesting the regenerative potential of ADSCs/decorin/gellan hydrogel for cartilage injury repair in preclinical medicine (Fig. 7).

Figure 7.

Schematic diagram of the injectable ADSCs-loaded decorin/gellan gum hydrogel for arthritis inflammatory microenvironment regulation. Integration of ADSCs and decorin in hydrogel results in cartilage ECM biomimetic and anti-inflammatory properties. ADSCs: adipose-derived stem cells; ECM: extracellular matrix.

ADSCs are multipotent and able to differentiate into chondrocytes. Arthroscopy injection of ADSCs improved cartilage regeneration and reduced pain in patients with OA. The efficacy of articular cartilage regeneration by MSCs-hydrogel composite was demonstrated by clinical trial⁵⁰. Ideal hydrogel matrix should be injectable for intra-articular implantation⁵¹, biomimetic for maintaining stem cell phenotype for chondrogenesis⁵², and particularly immunomodulated for inflammation attenuation⁵³. Naturally derived polymers, including gellan gum, can form hydrogels for MSCs encapsulation⁵⁴. Gellan gum hydrogel eye drop formulation was first developed by Hill et al²⁷. Our results confirmed the transition between solid and liquid states of gellan gum hydrogel, allowing loading of ADSCs followed by needle injection. We believe that the resting solid state of gellan gum hydrogel after intra-articular injection is beneficial not only for stem cell retention but also for application for three-dimensional tissue bioprinting manufacturing.

Three-dimensional culture of MSCs in the ECM motifs-modified gellan gum hydrogel presented higher proliferation and metabolic secrete factors when compared with commercially available hydrogel⁵⁵, indicating the importance of mimicking the ECM microenvironment for MSCs to maintain inflammation attenuation phenotype⁵³. Interestingly, trehalose-assisted gellan gum encapsulation of ADSC retained their differentiation phenotype under cryopreservation stress⁵⁶. The outcomes of our study confirmed that decorin supported the chondrogenesis of ADSCs in inflammatory circumstances. The decreased proliferation rate induced by IL-1β was also retained by decorin-assisted gellan gum hydrogel. A similar study on BMSCs pointed out that stiffness varying can form a suitable network for cartilage differentiation of BMSCs⁵⁷. There is evidence that ADSCs are more likely to differentiate into cartilage than BMSCs; therefore, optimization of hydrogel matrix stiffness favors for MSC chondrogenic differentiation was practicable⁵⁸. Considering decorin was necessary for maintaining fibril structure and mechanical stiffness of tendon and cartilage^59,60, we assumed that application of decorin in gellan gum could serve as viscous substrates to modulate stiffness in a microenvironment, which preserves ADSCs regenerative potential under inflammation.

On the other hand, decorin is known for its ability to adhere to the aggrecan network and mediate biomechanical transduction of cartilage⁶¹, which explains that decorin delays the loss of sulfated GAGs in chondrocyte induced by IL-1β stimulation²⁰. Here, we demonstrated that decorin-loaded gellan gum hydrogel increases the aggrecan expression in ADSCs with IL-1β activation, indicating that decorin regulates the integrity of the aggrecan network in the pericellular microenvironment⁶². Therefore, the chondromimetic matrix formulated by decorin gellan hydrogel may control the chondrogenic differentiation of ADSCs which is in line with other data⁶³. In addition, the decorin-based biomimetic scaffold has been shown suitable for promoting chondrogenic differentiation of ADSCs⁶⁴, suggesting the crucial role decorin plays in assembling chondromimetic hydrogel for cartilage regeneration. Taken together, combination of ADSCs and the extracellular decorin matrix may favor better participation in suppressing cartilage injury.

A previous study showed the possibility of the immuno-modulation capacity of decorin⁶⁵. Not surprisingly, IL-1β stimulation induces decorin production in human stromal cells⁶⁶, indicating that decorin acts as a feedback regulation under the inflammatory microenvironment. Interestingly, decorin boosts pro-inflammatory signaling via Toll-like receptors in macrophages⁶⁷. However, Toll-like receptors are not dominantly expressed in ADSCs, suggesting that a different immunomodulatory role may decorin play in the ADSCs. Topical decorin reduces the infiltration of inflammatory macrophages and neutrophils in corneal inflammation^68,69, indicating the inflammation attenuating aspect of decorin on other cell types. Moreover, decorin overexpressing MSCs regulate inflammation in injuries via increasing the expression of anti-inflammatory cytokines²⁶. Our results showed a synergistic effect of decorin and ADSCs in inflammatory joint disorder; therefore, we assumed that decorin in the matrix could modulate ADSCs immunol phenotype to enhance the anti-inflammatory effect via cytokines paracrine action on chondrocytes. In line with these data, a co-culture-secreted protein study of MSCs and cartilage explants showed a protective effect of MSCs on IL-1β induced cartilage catabolic injury by increasing the decorin secretion²⁴.

ADSCs increase the autophagy flux in response to stress stimulations⁷⁰, probably via the Sirtuin-1-related autophagy pathway to attenuate oxidative stress-induced cell death⁷¹. Enhancing autophagy signaling in stress-challenged ADSCs plays a protective role in cell survival⁷². In addition, enhanced autophagy of ADSCs improves its stemness⁷³ and therefore promotes therapeutic effect under inflammation⁷⁴. Our results showed that decorin-laden hydrogel may increase autophagy signaling in ADSCs under IL-1β challenging. Previous studies revealed that proteoglycan could regulate the autophagy pathway in endothelial cells via outside-in signaling^31,75. Recent studies have shown that decorin can also induce autophagy and mitophagy. Decorin directly interacts with vascular endothelial growth factor receptor 2 to induce autophagy⁷⁶. We assumed that decorin-laden hydrogel may increase autophagy signaling in ADSCs via interacting with receptor tyrosine kinases under an inflammatory microenvironment. In fact, preconditioning induction of autophagy in ADSCs alters the immune phenotype and increases the expression of cytokines⁷⁷. Therefore, regulating the inflammatory “fingerprint” of ADSC by decorin may upregulate its anti-inflammatory potential. Interestingly, ADSCs itself could activate autophagy in chondrocytes for attenuating catabolism in an inflammation microenvironment⁷⁸, suggesting that released decorin may have a direct therapeutic effect via contacting chondrocytes.

There are some limitations in this study: (i) Comparison of the immune phenotype of the different magnitude of cell numbers in hydrogels could enhance the novelty of this study; (ii) using human-driven cells or decorin would complement the translational potential of this study; (iii) the underlying mechanism of decorin regulate autophagy in ADSCs is unknown; and (iv) tracking the distribution of ADSCs after intra-articular injection of the hydrogel would strengthen the research depth of this study. However, we could not underestimate the scientific novelty of this study which is the synergistic therapeutic effect of decorin/gellan gum/ADSCs hydrogel in favor of cartilage protection in inflammatory arthritis.

In summary, decorin/gellan gum hydrogel enhances the anti-inflammatory properties of encapsulating ADSCs. The regulating mechanism may be complemented by the ability of decorin to induce autophagy signaling and therefore modulates the immune response of ADSC in the inflammation microenvironment. Further research aimed at exploring a promising intra-articular injection candidate for the anti-inflammatory drug of decorin/gellan gum/ADSCs hydrogel in inflammatory joint disorder is warranted.

Footnotes

Acknowledgements

The authors thank the technician colleagues for their help in the study. The schematic diagram figure was drawn by Figdraw ().

Author Contributions

Conceptualization, W.H. and K.W.; methodology, W.H., Y.W., Z.L., G.Y., X.C., J.R., S.J., and K.W.; validation, W.H., Y.W., Z.L., G.Y., T.L., Z.L., and S.J.; formal analysis, W.H. and Y.W.; investigation, W.H., Y.W., Z.L., G.Y., W.Y., X.C., J.R., T.L., Z.L., S.J., and W.K.; resources, W.H., S.J., and K.W.; data curation, W.H., Y.W., W.Y., J.R., T.L., Z.L., S.J., and K.W.; writing—original draft preparation, W.H., Y.W., and S.J.; writing—review and editing, W.H., Z.L., S.J., and K.W.; supervision, W.H. and K.W.; project administration, W.H., S.J., and K.W.; funding acquisition, W.H. and K.W. All authors have read and agreed to the published version of the manuscript.

Availability of data and material

Data are available within the paper and on request from the corresponding authors.

Ethical Approval

This study was reviewed by the Dongguan Hospital of Integrated Traditional Chinese and Western Medicine Ethics and Institutional Review Committee, Dongguan, China.

Statement of Human and Animal Rights

All of the procedures involving animals were conducted in accordance with the Institutional Animal Care guidelines of Dongguan Hospital of Integrated Traditional Chinese and Western Medicine, Dongguan, China (2020-0112). This article does not contain any studies with human subjects.

Statement of Informed Consent

There are no human subjects in this article and informed consent is not applicable.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by the Medical Scientific Research Foundation of Guangdong Province, China (A2020393) and the Dongguan Science and Technology of Social Development Program (20221800906152 and 20211800904092). This research was partly supported by the Guangzhou Key Research and Development Project (No. 2023B03J0211) and the Science and Technology Planning Project of Guangdong Province (No. 2023A1515012621).

ORCID iD

Kun Wang

References

Veronesi

Maglio

Tschon

Aldini

Fini

. Adipose-derived mesenchymal stem cells for cartilage tissue engineering: state-of-the-art in in vivo studies. J Biomed Mater Res A. 2014;102(7):2448–66.

Fodor

Paulseth

. Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint. Aesthet Surg J. 2016;36(2):229–36.

Lee

Shin

Kim

Chai

Jeong

Kim

Shim

Shin

, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014;32(5):1254–66.

Delanois

Etcheson

Sodhi

Henn

3rd Gwam

George

Mont

. Biologic therapies for the treatment of knee osteoarthritis. J Arthroplasty. 2019;34(4):801–13.

Kuwasawa

Okazaki

Noda

Fukushima

Nihei

. Intra-articular injection of culture-expanded adipose tissue-derived stem cells for knee osteoarthritis: assessments with clinical symptoms and quantitative measurements of articular cartilage volume. J Orthop Sci. 2023;28(2):408–15.

Djouad

Bouffi

Ghannam

Noël

Jorgensen

. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol. 2009;5(7):392–99.

Ueyama

Okano

Orita

Mamoto

Sobajima

Iwaguro

Nakamura

. Local transplantation of adipose-derived stem cells has a significant therapeutic effect in a mouse model of rheumatoid arthritis. Sci Rep. 2020;10(1):3076.

Tossetta

Fantone

Licini

Marzioni

Mattioli-Belmonte

. The multifaced role of HtrA1 in the development of joint and skeletal disorders. Bone. 2022;157:116350.

Udomsinprasert

Jittikoon

Honsawek

. Interleukin-34 as a promising clinical biomarker and therapeutic target for inflammatory arthritis. Cytokine Growth Factor Rev. 2019;47:43–53.

10.

Bora

Majumdar

. Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther. 2017;8(1):145.

11.

Dubey

Wei

Williams

Wang

Deng

Tsai

Wang

Deng

. Adipose-derived stem cells attenuates diabetic osteoarthritis via inhibition of glycation-mediated inflammatory cascade. Aging Dis. 2019;10(3):483–96.

12.

Chang

Chiou

Chang

Liao

. Adipose-derived stem cell exosomes as a novel anti-inflammatory agent and the current therapeutic targets for rheumatoid arthritis. Biomedicines. 2022;10(7):1725.

13.

Cavallo

Merli

Zini

D’Adamo

Cattini

Guescini

Grigolo

Di Martino

Santi

Borzi

Filardo

. Small extracellular vesicles from inflamed adipose derived stromal cells enhance the NF-kappaB-dependent inflammatory/catabolic environment of osteoarthritis. Stem Cells Int. 2022;2022:9376338.

14.

Skalska

Kontny

Prochorec-Sobieszek

Maśliński

. Intra-articular adipose-derived mesenchymal stem cells from rheumatoid arthritis patients maintain the function of chondrogenic differentiation. Rheumatology (Oxford). 2012;51(10):1757–64.

15.

Djouad

Delorme

Maurice

Bony

Apparailly

Louis-Plence

Canovas

Charbord

Noël

Jorgensen

. Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. Arthritis Res Ther. 2007;9(2):R33.

16.

Wilda

Bächner

Just

Geerkens

Kraus

Vogel

Hameister

. A comparison of the expression pattern of five genes of the family of small leucine-rich proteoglycans during mouse development. J Bone Miner Res. 2000;15(11):2187–96.

17.

Salinas

Anseth

. Decorin moieties tethered into PEG networks induce chondrogenesis of human mesenchymal stem cells. J Biomed Mater Res A. 2009;90(2):456–64.

18.

Lewis

Krawczak

Oegema

Jr Westendorf

. Effect of decorin and dermatan sulfate on the mechanical properties of a neocartilage. Connect Tissue Res. 2010;51(2):159–70.

19.

Wilusz

Sanchez-Adams

Guilak

. The structure and function of the pericellular matrix of articular cartilage. Matrix Biol. 2014;39:25–32.

20.

Han

Wang

Tong

Wei

Tseng

Han

Liu

Enomoto-Iwamoto

Mauck

Qin

, et al. Mediation of cartilage matrix degeneration and fibrillation by decorin in post-traumatic osteoarthritis. Arthritis Rheumatol. 2020;72(8):1266–77.

21.

Bock

Michaeli

Bode

Schultz

Kresse

Herken

Miosge

. The small proteoglycans decorin and biglycan in human articular cartilage of late-stage osteoarthritis. Osteoarthritis Cartilage. 2001;9(7):654–63.

22.

Polgar

Falus

Koo

Ujfalussy

Sesztak

Szuts

Konrad

Hodinka

Bene

Meszaros

Ortutay

, et al. Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Rheumatology (Oxford). 2003;42(4):522–27.

23.

Kydd

Reno

Tsao

Hart

. Early inflammatory arthritis in the rabbit: the influence of intraarticular and systemic corticosteroids on mRNA levels in connective tissues of the knee. J Rheumatol. 2007;34(1):130–39.

24.

Dechêne

Colin

Demazy

Fransolet

Niesten

Arnould

Serteyn

Dieu

Renard

. Characterization of the proteins secreted by equine muscle-derived mesenchymal stem cells exposed to cartilage explants in osteoarthritis model. Stem Cell Rev Rep. 2023;19(2):550–67.

25.

Dong

Zhong

Dong

. The role of decorin in autoimmune and inflammatory diseases. J Immunol Res. 2022;2022:1283383.

26.

Liu

Kong

Yuan

Seth

Wang

Xiao

Wang

Zhang

Yang

Wang

. Decorin-modified umbilical cord mesenchymal stem cells (MSCs) attenuate radiation-induced lung injuries via regulating inflammation, fibrotic factors, and immune responses. Int J Radiat Oncol Biol Phys. 2018;101(4):945–56.

27.

Hill

Moakes

RJA

Vareechon

Butt

Brock

Chouhan

Vincent

Abbondante

Williams

Barnes

, et al. Sustained release of decorin to the surface of the eye enables scarless corneal regeneration. NPJ Regen Med. 2018;3:23.

28.

Chouhan

Moakes

RJA

Esmaeili

Hill

deCogan

Hardwicke

Rauz

Logan

Grover

. A self-healing hydrogel eye drop for the sustained delivery of decorin to prevent corneal scarring. Biomaterials. 2019;210:41–50.

29.

Xing

Peng

Chen

Ding

Xie

. Gellan gum/alginate-based Ca-enriched acellular bilayer hydrogel with robust interface bonding for effective osteochondral repair. Carbohydr Polym. 2021;270:118382.

30.

Downie

Hill

Chinnery

. The effect of topical decorin on temporal changes to corneal immune cells after epithelial abrasion. J Neuroinflammation. 2022;19(1):90.

31.

Gubbiotti

Iozzo

. Proteoglycans regulate autophagy via outside-in signaling: an emerging new concept. Matrix Biol. 2015;48:6–13.

32.

Lin

Miao

Zhang

Wang

Feng

Bai

. JUNB-FBXO21-ERK axis promotes cartilage degeneration in osteoarthritis by inhibiting autophagy. Aging Cell. 2021;20(2):e13306.

33.

Pan

Wang

Hou

Zhang

. Autophagy regulates the therapeutic potential of adipose-derived stem cells in LPS-induced pulmonary microvascular barrier damage. Cell Death Dis. 2019;10(11):804.

34.

Shao

Shen

Wang

Mao

Shen

Chen

. Protection of adipose-derived mesenchymal stromal cells during acute lung injury requires autophagy maintained by mTOR. Cell Death Discov. 2022;8(1):481.

35.

Yin

Zheng

Chen

Jin

. Inhibition of autophagy promoted high glucose/ROS-mediated apoptosis in ADSCs. Stem Cell Res Ther. 2018;9(1):289.

36.

Neill

Chen

Buraschi

Iozzo

. Catabolic degradation of endothelial VEGFA via autophagy. J Biol Chem. 2020;295(18):6064–79.

37.

Zhang

Ding

Wang

Ding

Han

Dong

Jiang

. Decorin inhibits nucleus pulposus apoptosis by matrix-induced autophagy via the mTOR pathway. J Orthop Res. 2021;39(8):1777–88.

38.

Zuk

Zhu

Ashjian

De Ugarte

Huang

Mizuno

Alfonso

Fraser

Benhaim

Hedrick

. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279–95.

39.

Luo

Liang

Jiang

Bai

Wang

Zhu

. Autograft microskin combined with adipose-derived stem cell enhances wound healing in a full-thickness skin defect mouse model. Stem Cell Res Ther. 2019;10(1):279.

40.

Mousavi

Keshvari

Daemi

. Partial sulfation of gellan gum produces cytocompatible, body temperature-responsive hydrogels. Int J Biol Macromol. 2023;235:123525.

41.

Shah

Esdaille

Bhattacharjee

Kan

Laurencin

. The synthetic artificial stem cell (SASC): shifting the paradigm of cell therapy in regenerative engineering. Proc Natl Acad Sci U S A. 2022;119(2).

42.

Christin

Mouchbahani-Constance

Davidova

Sharif-Naeini

. Mechanosensitive ion channels in articular nociceptors drive mechanical allodynia in osteoarthritis. Osteoarthritis Cartilage. 2017;25(12):2091–99.

43.

Okun

Liu

Davis

Ren

Remeniuk

Brion

Ossipov

Xie

Dussor

King

Porreca

. Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain. 2012;153(4):924–33.

44.

Neill

Schaefer

Iozzo

. Decorin as a multivalent therapeutic agent against cancer. Adv Drug Deliv Rev. 2016;97:174–85.

45.

Pugsley

. Assessing autophagic flux by measuring LC3, p62, and LAMP1 Co-localization using multispectral imaging flow cytometry.J Vis Exp. 2017(125):55637.

46.

Tanida

Ueno

Kominami

. LC3 and autophagy. Methods Mol Biol. 2008;445:77–88.

47.

Choe

Jung

Park

Kim

. Enhanced p62 expression through impaired proteasomal degradation is involved in caspase-1 activation in monosodium urate crystal-induced interleukin-1b expression. Rheumatology (Oxford). 2014;53(6):1043–53.

48.

Buraschi

Neill

Goyal

Poluzzi

Smythies

Owens

Schaefer

Torres

Iozzo

. Decorin causes autophagy in endothelial cells via Peg3. Proc Natl Acad Sci USA. 2013;110(28):E2582–91.

49.

Yao

Zhang

Gong

Zhang

Wang

Ding

. Decorin-mediated inhibition of the migration of U87MG glioma cells involves activation of autophagy and suppression of TGF-beta signaling. FEBS Open Bio. 2016;6(7):707–19.

50.

Park

Lee

Yoon

Park

. Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord blood-derived mesenchymal stem cells and hyaluronate hydrogel: results from a clinical trial for safety and proof-of-concept with 7 years of extended follow-up. Stem Cells Transl Med. 2017;6(2):613–21.

51.

Zeng

Huang

Xiong

Huang

Xie

Shen

. Injectable decellularized cartilage matrix hydrogel encapsulating urine-derived stem cells for immunomodulatory and cartilage defect regeneration. NPJ Regen Med. 2022;7(1):75.

52.

Antich

Jiménez

de Vicente

López-Ruiz

Chocarro-Wrona

Griñán-Lisón

Carrillo

Montañez

Marchal

. Development of a biomimetic hydrogel based on predifferentiated mesenchymal stem-cell-derived ECM for cartilage tissue engineering. Adv Healthc Mater. 2021;10(8):e2001847.

53.

Zhu

Liu

Zhao

Sun

. ECM-inspired hydrogels with ADSCs encapsulation for rheumatoid arthritis treatment. Adv Sci (Weinh). 2023;10(9):e2206253.

54.

Gasperini

Mano

Reis

. Natural polymers for the microencapsulation of cells. J R Soc Interface. 2014;11(100):20140817.

55.

Silva

Moreira

Ribeiro-Samy

Gomes

Tam

Shoichet

Reis

Sousa

Salgado

. Modulation of bone marrow mesenchymal stem cell secretome by ECM-like hydrogels. Biochimie. 2013;95(12):2314–19.

56.

Tan

KYF

PLR

. Sugar-assisted cryopreservation of stem cell-laden gellan gum-collagen interpenetrating network hydrogels. Biomacromolecules. 2022;23(7):2803–13.

57.

Park

Choi

Lee

Been

Song

Khang

. Application of double network of gellan gum and pullulan for bone marrow stem cells differentiation towards chondrogenesis by controlling viscous substrates. J Tissue Eng Regen Med. 2020;14(11):1592–603.

58.

Liu

Wong

Tan

Goh

JCH

. The effect of chondroitin sulfate concentration and matrix stiffness on chondrogenic differentiation of mesenchymal stem cells. Biomater Sci. 2023;11:4557–73.

59.

Robinson

Sun

Barnum

Weiss

Huegel

Shetye

Lin

Saez

Adams

Iozzo

Soslowsky

, et al. Decorin and biglycan are necessary for maintaining collagen fibril structure, fiber realignment, and mechanical properties of mature tendons. Matrix Biol. 2017;64:81–93.

60.

Gronau

Krüger

Prein

Aszodi

Gronau

Iozzo

Mooren

Clausen-Schaumann

Bertrand

Pap

Bruckner

, et al. Forced exercise-induced osteoarthritis is attenuated in mice lacking the small leucine-rich proteoglycan decorin. Ann Rheum Dis. 2017;76(2):442–49.

61.

Han

Wang

Patel

Adams

Doyran

Nia

Oftadeh

Zhou

Liu

, et al. Decorin regulates the aggrecan network integrity and biomechanical functions of cartilage extracellular matrix. ACS Nano. 2019;13(10):11320–33.

62.

Chery

Han

Zhou

Wang

Adams

Chandrasekaran

Kwok

Heo

Enomoto-Iwamoto

Kong

, et al. Decorin regulates cartilage pericellular matrix micromechanobiology. Matrix Biol. 2021;96:1–17.

63.

Ansboro

Hayes

Barron

Browne

Howard

Greiser

Lalor

Shannon

Barry

Pandit

Murphy

. A chondromimetic microsphere for in situ spatially controlled chondrogenic differentiation of human mesenchymal stem cells. J Control Release. 2014;179:42–51.

64.

Recha-Sancho

Semino

. Chondroitin sulfate- and decorin-based self-assembling scaffolds for cartilage tissue engineering. Plos One. 2016;11(6):e0157603.

65.

Zwambag

Molladavoodi

Guerreiro

DeWitte-Orr

Gregory

. Immuno-stimulatory capacity of decorin in the rat tail intervertebral disc and the mechanical consequence of resultant inflammation. Eur Spine J. 2020;29(7):1641–48.

66.

Halari

Renaud

Lala

. Molecular mechanisms in IL-1beta-mediated decorin production by decidual cells. Mol Hum Reprod. 2021;27(12):gaab068.

67.

Merline

Moreth

Beckmann

Nastase

Zeng-Brouwers

Tralhao

Lemarchand

Pfeilschifter

Schaefer

Iozzo

Schaefer

. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal. 2011;4(199): ra75.

68.

Downie

Hill

Chinnery

. Topical decorin reduces corneal inflammation and imparts neuroprotection in a mouse model of benzalkonium chloride-induced corneal neuropathy. Invest Ophthalmol Vis Sci. 2023;64(2):20.

69.

Downie

Grover

Moakes

RJA

Rauz

Logan

Jiao

Hill

Chinnery

. The neuroregenerative effects of topical decorin on the injured mouse cornea. J Neuroinflammation. 2020;17(1):142.

70.

Yang

Huang

Hsu

. Enhanced autophagy of adipose-derived stem cells grown on chitosan substrates. Biores Open Access. 2015;4(1):89–96.

71.

Liu

Ouyang

Chen

Lin

Liu

Xiao

Huang

. SIRT1 reverses senescence via enhancing autophagy and attenuates oxidative stress-induced apoptosis through promoting p53 degradation. Int J Biol Macromol. 2018;117:225–34.

72.

Chen

Jia

Ding

Jiang

Zhang

. AMPK promotes survival and adipogenesis of ischemia-challenged ADSCs in an autophagy-dependent manner. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(12):1498–510.

73.

Chinnapaka

Yang

Flowers

Faisal

Nerone

Rubin

Ejaz

. Metformin improves stemness of human adipose-derived stem cells by downmodulation of mechanistic target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK) signaling. Biomedicines. 2021;9(12):1782.

74.

Yin

Chen

Yang

Jin

. AURKA enhances autophagy of adipose derived stem cells to promote diabetic wound repair via targeting FOXO3a. J Invest Dermatol. 2020;140(8):1639–49.

75.

Gubbiotti

Neill

Frey

Schaefer

Iozzo

. Decorin is an autophagy-inducible proteoglycan and is required for proper in vivo autophagy. Matrix Biol. 2015;48:14–25.

76.

Buraschi

Neill

Iozzo

. Decorin is a devouring proteoglycan: remodeling of intracellular catabolism via autophagy and mitophagy. Matrix Biol. 2019;75–76:260–70.

77.

Wise

Al-Ghadban

Harrison

MAA

Sullivan

Monaco

Aleman

Donato

Bunnell

. Short-term autophagy preconditioning upregulates the expression of COX2 and PGE2 and alters the immune phenotype of human adipose-derived stem cells in vitro. Cells. 2022;11(9):1376.

78.

Jiang

Lee

Wang

Meng

Zhang

. Adipose-derived stem cells induce autophagic activation and inhibit catabolic response to pro-inflammatory cytokines in rat chondrocytes. Osteoarthritis Cartilage. 2016;24(6):1071–81.